Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

Novartis Consumer Health named Clearasil distributor in U.S., Canada effective July 2 to strengthen position of skin care brand, UK firm announces. Former Clearasil marketer Procter & Gamble will distribute brand until July 1 and continue to manufacture it in North America until further notice, Boots says. Novartis and Boots will work together to evaluate opportunities for Clearasil, including revamping the line and possibly bringing other Boots OTCs under development in UK to U.S. market, firm says. Boots purchased Clearasil from P&G for $340 mil. (1"The Tan Sheet" Oct. 23, 2000, p. 7)

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts